688197.SS · 首药控股
China A-shares · RS rating 36 · As of 2026-10-14
| Price | 32.48 CNY |
|---|---|
| 1-day change | -2.2% |
| RS rating (overall / 1M / 3M / 12M) | 36 / 65 / 27 / 24 |
| Stage | Basing |
| Composite / Minervini / CANSLIM score | 29 / 18 / 13 |
| Industry group (rank) | Medical-Biomed/Biotech (68) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | -100.0% |
| Distance from 52-week high | +32.7% |
| Market cap (USD) | $772.9M |